Amphera

Developing dendritic cell immunotherapies for treating malignant mesothelioma and other cancers

placeS Hertogenbosch, North Brabant, Netherlands calendar_todayFounded 2012 groups4 employees language amphera.nl

Social engagement

Social engagement: 659 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Brabant Life Sciences Seed Fund.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%
Coming soon